Author | William Stohl MD PhD


Four Basics About BAFF Inhibitors for SLE

January 03, 2014

Last year's approval of belimumab (Benlysta) revolutionized lupus treatment. How safe and effective is it, actually? Do similar inhibitors of the B-cell activating factor BAFF, now in testing, appear even more promising? Here are the basics from an expert on the subject.